Equitable Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-9,725
Closed -$1.63M 293
2019
Q2
$1.63M Buy
9,725
+170
+2% +$23.5K 0.17% 116
2019
Q1
$1.4M Buy
9,555
+750
+9% +$109K 0.16% 128
2018
Q4
$1.18M Buy
8,805
+1,960
+29% +$321K 0.16% 130
2018
Q3
$1.3M Buy
6,845
+1,600
+31% +$294K 0.15% 135
2018
Q2
$874K Buy
+5,245
New +$842K 0.11% 149

Other funds holding AGN

Equitable Trust's AGN Position: Q3 2019 in Review

Equitable Trust sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 9,725 shares — an estimated $1.63M sold.

Equitable Trust first reported a position in AGN in Q2 2018 and held it in 5 quarters. The position peaked at $1.63M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Equitable Trust reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Equitable Trust sold 9,725 Allergan plc shares in Q3 2019, an estimated $1.63M.
  • Equitable Trust first reported a position in Allergan plc in Q2 2018 and held it in 5 quarters.
  • Equitable Trust's Allergan plc position peaked at $1.63M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Equitable Trust's 13F filing for Q3 2019, filed 19 Nov 2019.